Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Goodwill (2016 - 2017)

IGC Pharma (IGC) has disclosed Goodwill for 6 consecutive years, with $198169.0 as the latest value for Q4 2017.

  • Quarterly Goodwill changed 0.09% to $198169.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $198169.0 through Dec 2017, changed 0.09% year-over-year, with the annual reading at $198169.0 for FY2017, 83.22% down from the prior year.
  • Goodwill for Q4 2017 was $198169.0 at IGC Pharma, roughly flat from $198169.0 in the prior quarter.
  • The five-year high for Goodwill was $1.2 million in Q1 2016, with the low at $198000.0 in Q4 2016.
  • Average Goodwill over 4 years is $695348.1, with a median of $982782.0 recorded in 2014.
  • The sharpest move saw Goodwill grew 20.16% in 2016, then plummeted 83.22% in 2017.
  • Over 4 years, Goodwill stood at $982782.0 in 2014, then changed by 0.0% to $982782.0 in 2015, then crashed by 79.85% to $198000.0 in 2016, then increased by 0.09% to $198169.0 in 2017.
  • According to Business Quant data, Goodwill over the past three periods came in at $198169.0, $198169.0, and $198169.0 for Q4 2017, Q3 2017, and Q2 2017 respectively.